Vaasa Central Hospital

At Vaasa Central Hospital, research in diagnosis includes studies that look at better ways to assess urgent conditions and improve imaging decisions for people with complex medical needs. The focus is on making diagnostic pathways more accurate and practical in everyday care.

• Improving the diagnostic approach for acute abdominal conditions in patients with impaired kidney function
• Evaluating imaging strategies for emergency care when renal function is reduced
• Supporting safer and more effective diagnostic decision-making in routine hospital practice

This area reflects a strong interest in refining diagnostic techniques so clinicians can identify serious illness faster while reducing unnecessary risk.

Cardiovascular research at this site centers on preventing serious clot-related events in people with atrial fibrillation, chronic kidney disease, and recent stroke or high-risk transient ischemic attack. The trials are designed to test whether new treatment approaches can lower the chance of recurrent vascular events.

• Preventing ischemic stroke after a recent stroke or high-risk transient ischemic attack
• Studying anticoagulation strategies in atrial fibrillation with advanced kidney disease
• Assessing treatment options that may reduce systemic embolism and improve safety

These studies address important questions in cardiovascular disease, especially where balancing benefit and bleeding risk is clinically challenging.

In the field of female urogenital diseases, the trials at Vaasa Central Hospital focus mainly on breast cancer and treatment-related symptoms in women receiving endocrine therapy. The research aims to improve disease control, support quality of life, and reduce bothersome side effects.

• Testing new treatment options for early, advanced, and metastatic breast cancer
• Evaluating therapies for hormone receptor-positive, HER2-negative disease
• Studying approaches to relieve vasomotor symptoms caused by cancer treatment

This work combines oncology and symptom management, with attention to both cancer outcomes and day-to-day well-being.

The largest share of research at this site is in neoplasms, especially lung cancer, breast cancer, prostate cancer, and colorectal cancer. These studies are exploring whether new therapies, combinations, and treatment strategies can improve survival, delay progression, and expand options for patients with advanced disease.

• Evaluating immunotherapy combinations for non-small cell lung cancer
• Studying new approaches for advanced and metastatic breast cancer
• Assessing treatments for metastatic and high-risk prostate cancer
• Investigating options for relapsed small cell lung cancer and metastatic colorectal cancer
• Testing therapies intended to improve progression-free survival and overall disease control

The Department of Clinical Oncology is actively involved in research that aims to bring more effective cancer treatments into routine care across several major tumor types.

Some studies at Vaasa Central Hospital span broader clinical questions that do not fit neatly into a single disease category. These trials often examine general treatment effectiveness, safety, or outcomes across groups of patients with advanced illness.

• Monitoring the safety of new treatment combinations
• Comparing overall response and disease control between treatment approaches
• Supporting research that may inform future care across multiple cancer types

With 20 clinical trials and 10 investigators, the site shows a broad and active research profile across both cancer and non-cancer conditions.